التفاصيل البيبلوغرافية
| العنوان: |
[AUTOLOGOUS SERUM AS A TREATMENT FOR THE OCULAR SURFACE DISEASE]. |
| المؤلفون: |
Hayat H; Department of Ophthalmology, Barzilai Medical Center, Israel., Masarwa D; Department of Ophthalmology, Barzilai Medical Center, Israel. |
| المصدر: |
Harefuah [Harefuah] 2023 Mar; Vol. 162 (3), pp. 187-188. |
| نوع المنشور: |
English Abstract; Journal Article |
| اللغة: |
Hebrew |
| بيانات الدورية: |
Publisher: Israel Medical Association Country of Publication: Israel NLM ID: 0034351 Publication Model: Print Cited Medium: Print ISSN: 0017-7768 (Print) Linking ISSN: 00177768 NLM ISO Abbreviation: Harefuah Subsets: MEDLINE |
| أسماء مطبوعة: |
Original Publication: Tel Aviv : Israel Medical Association |
| مواضيع طبية MeSH: |
Dry Eye Syndromes*/drug therapy , Ophthalmology*, Humans ; United States ; Ophthalmic Solutions/therapeutic use ; Tears ; Serum |
| مستخلص: |
Introduction: The autologous serum drops treatment is an advanced, effective and safe treatment for severe dry eye and recurrent epithelial erosions. It contains growth factors, proteins, and vitamins, similar to the tear layer. In a recent review by the American Academy of Ophthalmology, many studies included showed a significant effect of serum drops in treating dry eye and recurrent epithelial erosions. Notwithstanding the above, to date, no randomized controlled clinical trials have investigated the effectiveness of autologous serum drops. Moreover, serum drops concoction has strict regulations, and in Israel, it is available in a small handful of hospitals, which causes limited accessibility to this valuable treatment. Precautions must be taken when using serum drops to avoid bottle contamination and infections during storage. |
| المشرفين على المادة: |
0 (Ophthalmic Solutions) |
| تواريخ الأحداث: |
Date Created: 20230404 Date Completed: 20230405 Latest Revision: 20230405 |
| رمز التحديث: |
20240513 |
| PMID: |
37012680 |
| قاعدة البيانات: |
MEDLINE |
